The Department of Health (DH) today (4 May) endorsed two licensed drug wholesalers, namely Trackcircle.com Limited (Trackcircle) and Link Healthcare Hong Kong Limited (Link) to recall Thioridazine HCl Tablets 25mg (Neuraxpharm), from the market due to possible quality defect of the product. The product is an unregistered pharmaceutical product imported for the treatment of particular patients.
The DH received notifications from the above wholesalers that serious deficiency was noted in the Good Manufacturing Practice of the manufacturer of the active pharmaceutical ingredient in the product, and therefore the quality of the finished product cannot be ascertained. As a precautionary measure, the wholesalers are voluntarily recalling the product from the market.
The product, containing thioridazine, is a prescription medicine used for the treatment of schizophrenia. According to the wholesalers, the product has solely been supplied to the Hospital Authority for the treatment of particular patients. The wholesalers have set up hotlines to answer related enquiries.
Trackcircle 3527 0198
Link 3907 0637
The DH will closely monitor the recall. So far, the department has not received any adverse reports in connection with the product concerned.
"People who have used the above product should contact their doctors for appropriate arrangement." a DH spokesperson said.
Reposted from HKSAR Government webpage: